• Users Online: 66
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Effects of ranibizumab on very low birth weight infants with stage 3 retinopathy of prematurity: A preliminary report☆

Lin Chun-Ju, Chen San-Ni, Tseng Chien-Chi, Chang Yao-Chung, Hwang Jiunn-Feng

Year : 2012| Volume: 2| Issue : 4 | Page no: 136-139

   This article has been cited by
 
1 Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
Nada O. Taher, Abdullah A. Ghaddaf, Sarah A. Al-Ghamdi, Jumanah J. Homsi, Bandar J. Al-Harbi, Lugean K. Alomari, Hashem S. Almarzouki
Frontiers in Medicine. 2022; 9
[Pubmed]  [Google Scholar] [DOI]
2 Analysis of the Recurrence of Plus Disease after Intravitreal Ranibizumab as a Primary Monotherapy for Severe Retinopathy of Prematurity
Odalis Arámbulo,Gabriel Dib,Juan Iturralde,Miguel Brito,Joăo B. Fortes Filho
Ophthalmology Retina. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Histological and Immunohistochemical Retinal Changes Following the Intravitreal Injection of Aflibercept, Bevacizumab and Ranibizumab in Newborn Rabbits
Duygu Cam,Ayse Tulin Berk,Serap Cilaker Micili,Tuncay Kume,Bekir Ugur Ergur,Osman Yilmaz
Current Eye Research. 2017; 42(2): 315
[Pubmed]  [Google Scholar] [DOI]
4 INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY
San-Ni Chen,Iebin Lian,Ya-Chi Hwang,Yi-Hsing Chen,Yao-Chung Chang,Kun-Hsien Lee,Chih-Chun Chuang,Wei-Chi Wu
Retina. 2015; 35(4): 667
[Pubmed]  [Google Scholar] [DOI]
5 Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
Simona Delia Nicoara,Constan?a Nascutzy,Cristina Cristian,Iulian Irimescu,Anne Claudia ?tefanu?,Gabriela Zaharie,Tudor Drugan
Journal of Ophthalmology. 2015; 2015: 1
[Pubmed]  [Google Scholar] [DOI]
6 Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease
Marcel N Menke,Carsten Framme,Mathias Nelle,Markus R Berger,Veit Sturm,Sebastian Wolf
BMC Ophthalmology. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
7 Anti-vascular endothelium growth factor therapy for retinopathy of prematurity: A continuing debate
Chang-Hao Yang
Taiwan Journal of Ophthalmology. 2012; 2(4): 115
[Pubmed]  [Google Scholar] [DOI]

 

Read this article